Grow your own heart valve: first human trial launches

NCT ID NCT05809856

Recruiting now Disease control Sponsor: Charite University, Berlin, Germany Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new type of heart valve made from a patient's own tissue to treat a leaky pulmonary valve. Seven adults will receive the valve to see if it is safe and works well in the short term. The valve is designed to grow with the patient, potentially reducing the need for repeat surgeries.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PULMONARY VALVE INSUFFICIENCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

congenital heart disease pulmonary valve insufficiency

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PULMONARY VALVE INSUFFICIENCY

Contacts and locations

Locations

Charité Universitätsmedizin Berlin, Campus Virchow Klinikum, Deutsches Herzzentrum der Charité
RECRUITING

Berlin, State of Berlin, 13353, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.